A Reference Guide to Antibody-Based Biomarkers in Neurological Disease

ALOMONE LABS NEWS

From glial activation to synaptic remodeling, here’s what antibody detection actually reveals about neurological disease.

Antibody-based protein markers remain a fundamental tool in both research and diagnostics for neurological disorders. But the list of available targets keeps growing – and not all are equally reliable, interpretable, or accessible across sample types.

You’ll find examples supported by validated Alomone Labs antibodies, including:

Anti-GFAP Antibody (#AFP-001)

Anti-Alpha-Synuclein Antibody (#APZ-035)

Anti-Synaptophysin Antibody (#ANR-013)

— trusted by researchers worldwide for their specificity and proven performance across applications.

We provide a clear overview of commonly used and reliable protein markers across neurodegenerative diseases (Alzheimer’s, Parkinson’s, Huntington’s, ALS), neuroinflammatory conditions (multiple sclerosis, epilepsy), and synaptic pathology, describing reliable protein targets, their distribution (tissue, CSF, blood), and biological significance.

Discover more https://www.alomone.com/antibody-based-biomarkers-for-neurological-disorders-key-proteins-and-detection-methods

Per maggiori info Contattaci